Cargando…

Diagnosis of Alzheimer’s Disease with [18F]PET in Mild and Asymptomatic Stages

With longer life expectancy, dementia based on the age-related Alzheimers’ disease (AD) has turned into one of the most prevalent disorders of older age, representing a serious medical and socio-economic issue. There has been growing interest in early diagnosis of this disease, particularly regardin...

Descripción completa

Detalles Bibliográficos
Autor principal:	Drzezga, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444274/ https://www.ncbi.nlm.nih.gov/pubmed/19847049 http://dx.doi.org/10.3233/BEN-2009-0228

Ejemplares similares

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer’s Disease
por: Li, Rui, et al.
Publicado: (2015)

The utility of (18)F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis
por: Zhang, Qingyu, et al.
Publicado: (2020)

Multicenter (18)F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
por: Rullmann, Michael, et al.
Publicado: (2022)

(18)F-FDG-PET in Mouse Models of Alzheimer's Disease
por: Bouter, Caroline, et al.
Publicado: (2019)

First Clinical Experience With [(68)Ga]Ga-FAPI-46-PET/CT Versus [(18)F]F-FDG PET/CT for Nodal Staging in Cervical Cancer
por: Wegen, Simone, et al.
Publicado: (2023)

A Case Report of Early-Onset Alzheimer’s Disease Using (18)F-FDG PET and (18)F-FBB PET
por: Yoo, Jang, et al.
Publicado: (2023)

Correction: (18)F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases
por: Grimmer, Timo, et al.
Publicado: (2018)

Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis
por: Morris, Elizabeth, et al.
Publicado: (2015)

Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images
por: Shen, Ting, et al.
Publicado: (2019)

Comparison of (18)F-T807 and (18)F-THK5117 PET in a Mouse Model of Tau Pathology
por: Brendel, Matthias, et al.
Publicado: (2018)

Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on (18)F-FDG PET/CT and Automated Classifiers
por: Nuvoli, Susanna, et al.
Publicado: (2022)

(18)F-FDG PET for Prediction of Conversion to Alzheimer’s Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy
por: Smailagic, Nadja, et al.
Publicado: (2018)

Association of the top 20 Alzheimer's disease risk genes with [(18)F]flortaucipir PET
por: Stage, Eddie, et al.
Publicado: (2022)

Clinical application of Al(18)F-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to (18)F-FDG
por: Lyu, Zhehao, et al.
Publicado: (2023)

Clinical validity of increased cortical uptake of [(18)F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework
por: Wolters, E. E., et al.
Publicado: (2021)

Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study
por: Pagani, M., et al.
Publicado: (2014)

[(18)F]THK-5351 PET Patterns in Patients With Alzheimer’s Disease and Negative Amyloid PET Findings
por: Oh, Minyoung, et al.
Publicado: (2022)

Evaluation of 3-l- and 3-d-[(18)F]Fluorophenylalanines as PET Tracers for Tumor Imaging
por: Krämer, Felicia, et al.
Publicado: (2021)

Tracer‐specific reference tissues selection improves detection of (18)F‐FDG, (18)F‐florbetapir, and (18)F‐flortaucipir PET SUVR changes in Alzheimer's disease
por: Li, Yanxiao, et al.
Publicado: (2022)

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with (18)F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders
por: Siderowf, Andrew, et al.
Publicado: (2014)

A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET
por: Etminani, Kobra, et al.
Publicado: (2021)

[(18)F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer
por: Dietlein, Felix, et al.
Publicado: (2020)

Head-to-Head Comparison of [(68) Ga]Ga-FAPI-46-PET/CT and [(18)F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer
por: Wegen, Simone, et al.
Publicado: (2022)

[(18)F]THK5351 PET Imaging in Patients with Mild Cognitive Impairment
por: Jeong, Hye Jin, et al.
Publicado: (2020)

Is Amyloid Burden Measured by (18)F-Flutemetamol PET Associated with Progression in Clinical Alzheimer’s Disease?
por: Müller, Ebba Gløersen, et al.
Publicado: (2022)

Visually Identified Tau (18)F-MK6240 PET Patterns in Symptomatic Alzheimer’s Disease
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Sleep Dysregulation Is Associated with (18)F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
por: Fernandes, Mariana, et al.
Publicado: (2023)

(18)F-FDG Uptake on PET/CT in Symptomatic versus Asymptomatic Carotid Disease: a Meta-Analysis
por: Chowdhury, Mohammed M., et al.
Publicado: (2018)

Assessment of Tau Pathology as Measured by (18)F-THK5317 and (18)F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer’s Disease
por: Colato, Elisa, et al.
Publicado: (2021)

Evaluation of the early-phase [(18)F]AV45 PET as an optimal surrogate of [(18)F]FDG PET in ageing and Alzheimer’s clinical syndrome
por: Vanhoutte, Matthieu, et al.
Publicado: (2021)

Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
por: Lin, Huan-Chun, et al.
Publicado: (2023)

(18)F-Florbetaben Amyloid PET Imaging: A Chinese Study in Cognitive Normal Controls, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
por: Chang, Yan, et al.
Publicado: (2020)

The correlation of neuropsychological evaluation with (11)C-PiB and (18)F-FC119S amyloid PET in mild cognitive impairment and Alzheimer disease
por: Park, Su Yeon, et al.
Publicado: (2020)

Evaluation of Imaging Windows for Tau PET Imaging Using (18)F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
por: Chotipanich, Chanisa, et al.
Publicado: (2020)

(18)F-FDG PET-CT for Staging of Conjunctival Melanoma
por: Damian, Andres, et al.
Publicado: (2013)

Effectiveness of (18)F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies
por: Liu, Fanxiao, et al.
Publicado: (2019)

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
por: Mistry, Vijay, et al.
Publicado: (2023)

A longitudinal (18)F-FDG PET/MRI study in asymptomatic stage of genetic Creutzfeldt–Jakob disease linked to G114V mutation
por: Chu, Min, et al.
Publicado: (2022)

The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging
por: Yousefi-Koma, Abbas, et al.
Publicado: (2013)

The Contribution of Fluorine (18)F-FDG PET/CT to Lung Cancer Diagnosis, Staging and Treatment Planning
por: Budak, Emine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4ktjs5iec2um1te44glrpngq54